| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Seelos Therapeutics Inc (NASDAQ: SEEL)
SEEL Technical Analysis
5
| As on 18th Nov 2024 SEEL STOCK Price closed @ 0.39 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.90 & Strong Sell for SHORT-TERM with Stoploss of 1.24 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SEELSTOCK Price
| Open | 0.50 | Change | Price | % |
| High | 0.50 | 1 Day | -0.32 | -45.07 |
| Low | 0.37 | 1 Week | -0.53 | -57.61 |
| Close | 0.39 | 1 Month | 0.08 | 25.81 |
| Volume | 55086 | 1 Year | -0.53 | -57.61 |
| 52 Week High 3.90 | 52 Week Low 0.11 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| NVDA | 146.67 | 0.53% |
| AKTS | 0.10 | 11.11% |
| WORX | 2.12 | 116.33% |
| QUBT | 4.76 | 29.35% |
| LMDX | 0.02 | 0.00% |
| SMCI | 29.70 | 5.06% |
| MSTR | 397.28 | -16.16% |
| MARA | 23.81 | 22.17% |
| CRNC | 5.83 | 106.74% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| SEEL Daily Charts |
SEEL Intraday Charts |
Whats New @ Bazaartrend |
SEEL Free Analysis |
|
|
SEEL Important Levels Intraday
| RESISTANCE | 0.64 |
| RESISTANCE | 0.56 |
| RESISTANCE | 0.51 |
| RESISTANCE | 0.46 |
| SUPPORT | 0.32 |
| SUPPORT | 0.27 |
| SUPPORT | 0.22 |
| SUPPORT | 0.14 |
SEEL Forecast November 2024
| 4th UP Forecast | 1.49 |
| 3rd UP Forecast | 1.14 |
| 2nd UP Forecast | 0.92 |
| 1st UP Forecast | 0.7 |
| 1st DOWN Forecast | 0.08 |
| 2nd DOWN Forecast | -0.14 |
| 3rd DOWN Forecast | -0.36 |
| 4th DOWN Forecast | -0.71 |
SEEL Weekly Forecast
| 4th UP Forecast | 0.70 |
| 3rd UP Forecast | 0.60 |
| 2nd UP Forecast | 0.54 |
| 1st UP Forecast | 0.48 |
| 1st DOWN Forecast | 0.30 |
| 2nd DOWN Forecast | 0.24 |
| 3rd DOWN Forecast | 0.18 |
| 4th DOWN Forecast | 0.08 |
SEEL Forecast2024
| 4th UP Forecast | 9 |
| 3rd UP Forecast | 6.24 |
| 2nd UP Forecast | 4.53 |
| 1st UP Forecast | 2.83 |
| 1st DOWN Forecast | -2.05 |
| 2nd DOWN Forecast | -3.75 |
| 3rd DOWN Forecast | -5.46 |
| 4th DOWN Forecast | -8.22 |
Seelos Therapeutics Inc ( NASDAQ USA Symbol : SEEL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SEEL Business Profile
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel technologies and therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients with PD; SLS-008, an orally available antagonist for chemoattractant receptor-homologous molecule for the treatment of chronic inflammation in asthma and pediatric orphan indications; SLS-004 for the treatment of PD; SLS-010, an oral histamine H3A receptor antagonist for narcolepsy and related disorders; and SLS-012, an injectable therapy for post-operative pain management. Seelos Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York. Address: 300 Park Avenue, New York, NY, United States, 10022
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service